Search

everythinglearnresearchcommunity

for

Search:↓

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Denosumab treatment for osteoporosis can cause hair loss.

Phototherapy can help treat hair loss in alopecia areata.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Infliximab may cause hair loss in Crohn's disease patients.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Alopecia Areata causes significant structural and compositional changes in hair.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Certain gene variations increase the risk of alopecia areata in Koreans.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Mouse models help understand alopecia areata and find treatments.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

An 82-year-old woman's hair turned white suddenly, likely due to a rare form of alopecia that targets pigmented hair.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.